Edition:
India

OPKO Health Inc (OPK.N)

OPK.N on New York Stock Exchange

10.75USD
29 Apr 2016
Change (% chg)

$-0.09 (-0.83%)
Prev Close
$10.84
Open
$10.82
Day's High
$10.97
Day's Low
$10.58
Volume
771,558
Avg. Vol
864,215
52-wk High
$19.19
52-wk Low
$7.13

OPK.N

Chart for OPK.N

About

OPKO Health, Inc. (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $5,867.78
Shares Outstanding(Mil.): 545.84
Dividend: --
Yield (%): --

Financials

  OPK.N Industry Sector
P/E (TTM): -- 34.16 45.44
EPS (TTM): -0.10 -- --
ROI: -1.30 13.08 12.53
ROE: -2.13 13.78 13.40
Search Stocks

BRIEF-OPKO Health presents additional data on rayaldee

* Data showed that mean plasma levels of iPTH and other markers of elevated bone metabolism gradually fell with rayaldee treatment Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

01 Apr 2016

BRIEF-Opko health provides additional data on kidney drug

* Presents additional data on rayaldee to treat secondary hyperparathyroidism in chronic kidney disease

31 Mar 2016

BRIEF-OPKO receives complete response letter from FDA for Rayaldee new drug application

* Opko Health Inc - Opko receives complete response letter from fda for rayaldee new drug application

30 Mar 2016

Competitors

Earnings vs. Estimates

Search Stocks